IL22RA1 and B-cell non-Hodgkin lymphoma: Studies have reported that T cells from anaplastic lymphoma and some B cell lymphoma lines may express this receptor, and forced expression of IL-22R1 on T and B cells results in generalized inflammation in mice suggesting that the signaling machinery utilizing this receptor subunit is present on T and B cells [50], [51], [52], [53].